School of Law

Books

• Dutfield GM (2009) Intellectual Property Rights and the Life Science Industries: Past, Present and Future World Scientific

• Dutfield GM (2008) Global Intellectual Property Law Edward Elgar

• Dutfield G (2004) Intellectual Property, Biogenetic Resources and Traditional Knowledge pp. xiii,258p Earthscan

• Dutfield G (2003) Intellectual Property Rights and the Life Science Industries: A Twentieth Century History pp. ix,288p Ashgate

Chapters

• Dutfield G (2005) Legal and Economic Aspects of Traditional Knowledge In: Reichman; Maskus (eds.) International Public Goods and Transfer of Technology under a Globalized Intellectual Property Regime pp. 495 - 520 Cambridge University Press

Conferences

• Dutfield G (2005) Intellectual property rights and gene-based technologies for animal production and health - Issues for developing countries pp. 499 - 520

  Author URL: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000233597800036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=378ec14fd3cd2d2d756f42f58f326e84

• Dutfield G (2004) What is biopiracy? pp. 89 - 92

  Author URL: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000243638100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=378ec14fd3cd2d2d756f42f58f326e84

• Dutfield G (2004) New forms of sui generis protection pp. 196 - 198

• Dutfield G (2002) Protecting traditional knowledge and folklore pp. 63 - 99

• Dutfield G "The Genetic Code is 3.6 billion years old. It's time for a rewrite": Biotech patenting in the 21st Century. Summer Institute in Intellectual Property, Biotechnology & Agricultural Sciences

Journal Articles

• Dutfield GM (2011) Patent on Steroids: What Hormones Tell Us about the Evolution of Patent Law In: Intellectual Property Journal 23 (3) pp. 249 - 266

  The hormones era from 1900 to the 1960s was a period of intensifying pharmaceutical industry internationalisation and competition within and across national boundaries. Patents and patent strategy were essential aspects of this evolutionary process. Hormones are chemical messengers produced by living organisms including humans. They form a wide range of products from anti-inflammatories to contraceptives. As soon as hormones were found to have commercial potential, industry faced the challenge of how to mass-produce them. This was obviously a scientific matter, but it was also a business issue and an intellectual property one. Both production pathways of extraction and hormone synthesis turned out to be equally capable of resulting in patentable subject matter. This was so even when said matter was based on a substance produced by an organism or else was a laboratory-produced copy of one. This set a historic precedent for the patenting of “natural” things like antibiotics, genes, cells, microbes, plants and animals. Thus, the patenting of hormones helped allow us to conceive of biotechnological products as patentable inventions.

• Dutfield GM (2011) A critical analysis of the debate on traditional knowledge, drug discovery and drug-based biopiracy In: European Intellectual Property Review 33 (4) pp. 237 - 243

• Dutfield G (2010) Why traditional knowledge is important in drug discovery In: FUTURE MEDICINAL CHEMISTRY 2 pp. 1405 - 1409

  Author URL: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000282245400008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=378ec14fd3cd2d2d756f42f58f326e84

• Dutfield GM (2010) Who invents life – blind watchmakers, intelligent designers or genetic engineers? In: Journal of Intellectual Property Law and Practice 5 (7) pp. 531 - 540 Oxford University Press

• Dutfield G (2008) Sustainable development in world trade law In: EUROPEAN LAW JOURNAL 14 pp. 387 - 388

• Dutfield G (2008) Delivering drugs to the poor: Will the TRIPS amendment help? In: AMERICAN JOURNAL OF LAW & MEDICINE 34 pp. 107 - 124

  Author URL: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000257636800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=378ec14fd3cd2d2d756f42f58f326e84

• Dutfield G (2007) Global biopiracy: Patents, plants and indigenous knowledge In: LAW & SOCIETY REVIEW 41 pp. 746 - 748

  Author URL: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000249184300011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=378ec14fd3cd2d2d756f42f58f326e84

• Dutfield G (2006) DNA patenting: implications for public health research In: BULLETIN OF THE WORLD HEALTH ORGANIZATION 84 pp. 388 - 392

• Dutfield G (2006) Patent Systems as Regulatory Institutions In: Indian Economic Journal 54 (1) pp. 62 - 90

• Dutfield G (2006) Piracy as Terrorism, Copying as Theft: The New Intellectual Property Fundamentalism in International Law and Politics In: None pp. 1361 - 4169

• Dutfield G (2005) Turning knowledge into power: intellectual property and the world trade system In: AUSTRALIAN JOURNAL OF INTERNATIONAL AFFAIRS 59 pp. 533 - 547

• Dutfield G (2005) Dangerous harvest: Drug plants and the transformation of indigenous landscapes. In: GEOGRAPHICAL JOURNAL 171 pp. 179 - 180

  Author URL: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000230553200007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=378ec14fd3cd2d2d756f42f58f326e84

• Dutfield G; Suthersanen U (2004) The Innovation Dilemma: Intellectual Property and the Historical Legacy of Cumulative Creativity In: Circulation Research 1 (4) pp. 379 - 421 Lippincott Williams & Wilkins

  patent and copyright law

• Seiler A; Dutfield G (2002) Regulating access and benefit sharing In: BIOTECHNOLOGY AND DEVELOPMENT MONITOR pp. 2 - 7

• Dutfield G (2001) TRIPS-Related Aspects of Traditional Knowledge In: Case Western Reserve Journal of International Law 33 (2) pp. 233 - 275 Cleveland, Ohio : the students of Case Western Reserve School of Law